Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Applied Clinical Medical Physics|May 24, 2021
Dosimetry with a clinical linac adapted to FLASH electron beamsStanislaw Szpala, Vicky Huang, Yingli Zhao, et al.
Health and Quality of Life Outcomes|June 25, 2017
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapyErica G Horodniceanu, Vasudha Bal, Harman Dhatt, et al.
Frontiers in Oncology|June 24, 2021
Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning ContoursJordan Wong, Vicky Huang, Joshua A Giambattista, et al.
Biochemical and Biophysical Research Communications|June 14, 2005
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL proteaseYu-Chih Liu, Vicky Huang, Ti-Chun Chao, et al.
Radiation Oncology (London, England)|June 9, 2021
Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centersJordan Wong, Vicky Huang, Derek Wells, et al.
Applied and Environmental Microbiology|August 29, 2025
Recovering wastewater RNA for virome sequencing by systematically optimized tangential-flow ultrafiltration and Nanotrap microbiome particlesEmily Segelhurst, Jonathan E Bard, Sydney Gallo, et al.
Health and Quality of Life Outcomes|November 21, 2018
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemiasAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
Radiation Oncology (London, England)|March 22, 2013
Template-based breast IMRT planning for increased workload efficiencySonia Kim Anh Nguyen, Fred Cao, Ramani Ramaseshan, et al.
American Journal of Hematology|February 1, 2017
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE studyAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2022
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized TrialMatthew Van Oirschot, Alanah Bergman, Wilko F A R Verbakel, et al.
Pageof 2